Advance Research Chemicals has been sold to Inhance Technologies, a portfolio company of Aurora Capital Partners
Advance Research Chemicals
Founded in 1987, Advance Research Chemicals (ARC) is world-class, specialty chemicals and materials supplier offering high purity, tailored solutions utilizing production facilities in the United States and Mexico. Many of the world’s largest companies partner with ARC to develop performance critical chemicals and materials that enable some of the most innovative products. The company also provides private label manufacturing for the institutional and consumer hygiene markets. ARC serves a wide array of industries, including medical batteries, semiconductors, 3D printing, pharmaceuticals, automotive, textiles and consumer packaged goods.
Lincoln’s industry expertise and access to global strategic and financial buyers enabled a targeted process to be run on an accelerated timeline with the best group of buyers. The acquisition of ARC is Inhance’s second add-on acquisition since being acquired by Aurora and helps to capitalize on existing technologies while delivering an even broader suite of specialty chemicals solutions. Randy Moser, Partner at Aurora Capital Partners, commented, “Leveraging the world-class capabilities of each company will spur even more technological advancements, durably accelerating Inhance Technologies’ growth.”
Chris Petrossian, Managing Director, commented, “ARC is a truly differentiated company in the specialty chemicals market with world-leading expertise in niche, inorganic chemistries. Inhance is the best strategic fit for ARC, and Aurora Capital Partners is a tremendous partner with a proven track record in the space. The synergies of the combined platform will accelerate growth and innovation to new heights.”
The Lincoln team's dedication and hard work as our advisor gave confidence that we would find the best home for our company and honor the legacy our family has built. Lincoln's strong relationships with the best buyers around the globe and deep sector expertise proved instrumental in executing a transaction in a timely manner at the best price and terms.
Meet our Senior Team
View More Transactions In Chemicals
Lincoln International advised SK Capital Partners on the sale of NuCera Solutions to Chase Corporation
Lincoln International has advised Highlander Partners on the sale of QTI Fibers to Norwest Equity Partners
Lincoln International advised shareholders of Ashapura on the sale of its majority stake to Azelis
Lincoln International has advised Creafund and private shareholders on the sale of Aalterpaint to Quva
Lincoln International has represented Intarome in its merger with Premier Specialties and Fragrance Solutions, supported by investment from The Riverside Company
Lincoln International is pleased to announce that ATDBio has been sold to Biotage
Lincoln International is pleased to announce that TTI Sports International, a portfolio company of Arlington Capital Partners, has been sold to Strait Lane Capital Partners
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.